VISTAGEN THERAPEUTICS INC (VTGN)

US92840H4002 - Common Stock

3.34  +0.02 (+0.75%)

After market: 3.4 +0.06 (+1.8%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2024
(2024-3-31)
2023
(2023-3-31)
2022
(2022-3-31)
2021
(2021-3-31)
Revenue
875.70K1.06M-230.00K1.11M1.09M
Gross Profit
N/AN/AN/A1.11M1.09M
Operating Expenses
46.48M34.09M59.04M48.89M19.02M
Research and Development
29.84M20.02M44.28M35.31M12.41M
Selling, General, and Administrative Expenses
16.64M14.06M14.66M13.48M6.55M
Operating Income
-45.60M-33.02M-59.27M-47.78M-17.93M
Interest Income/Expense
5.73M3.35M30.00K20.00K0.00
Other Income/Expense
N/A312.00KN/A0.000.00
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-39.56M-29.36M-59.24M-47.76M-17.93M
Income Tax
8.50K4.00K10.00K0.000.00
Net Income
-39.57M-29.36M-59.25M-48.71M-42.32M
EBITDA
-45.46M-32.89M-59.14M-47.63M-17.81M
 
Per Share Data
EPS Diluted Total Ops
-1.30-1.52-8.51-7.38-14.74
Non GAAP EPS
-1.24N/A-8.65-2.86-0.39
 
Statistics
Gross Profit Margin
N/AN/AN/A100.00%100.00%
Profit Margin
-4518.12%-2759.59%25760.87%-4388.29%-3882.57%
Operating Profit Margin
-5207.38%-3103.48%25769.57%-4304.50%-1644.95%

All data in USD

Charts